MoraeSpend Intelligence
Life Sciences edition

Explain the IP variance before cutting fees

Global IP budget, FY28 planning · model filing commitments before requesting more budget
Scenario · not an approved planSave scenario for GC review
$54.0M
Approved budget
$58.1M
Current expected annual cost · 2,060 families × $28.2K expected annual cost
—
modeled
—
Unresolved gap after modeled actions
Why the plan changed
Variance decomposed from matter-level data; volume forecast from Anaqua
DriverContributionImpact
Original plan · 1,800 families × $30,000
$54.0M
Filing volume · 260 extra families × $11,000
Pipeline-driven; GLP-1 and oncology programs
+$2.86M
Jurisdictions per family · 2,060 × $240
12.4 vs 11.1 planned
+$494K
Office-action count · 2,060 × $210
AU 1600 OAs per grant up to 2.9
+$433K
Renewals and FX
JPY/EUR annuities
+$313K
Expected annual cost$58.1M
Management implication. Filing volume explains $2.9M of the $4.1M and is a business decision, not a legal one. Fee pressure on firms addresses under $0.5M. Prune renewals with no business relevance, reallocate AU 1600 work by OA count, and fund the volume.
Model available actions
Overlaps removed before totals · tick to test
$900K
$1.1M
$700K
$400K
Selected actions—Overlapping benefit removed—Net modeled reduction—Unresolved gap to fund or accept—
These are assumptions to test. Provider capacity, matter quality and exceptions can change the result; each action becomes a decision record with an owner, a baseline and a follow-up date once saved.
Forecast range before actions: $55.2M–$61.9M (p10–p90 from pipeline and OA-count simulation; not a point estimate)
Inspect comparable firmsOpen phase comparisonsPatent portfolio